ID
43573
Descrizione
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome for internal use, not to be databased
Keywords
versioni (3)
- 12/09/17 12/09/17 -
- 12/09/17 12/09/17 -
- 20/09/21 20/09/21 -
Caricato su
20 settembre 2021
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
Similar models
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
C3174092 (UMLS CUI [1,2])